Identifying the Drivers of Patient Persistence and Compliance with Instructed Rx Therapy
Direct-to-consumer advertising (DTC) has successfully generated awareness, expanded markets, and motivated consumers to seek prescription drug treatment for their chronic and episodic illnesses. Popular DTC drug classes such as statins, proton pump inhibitors (PPIs), and asthma controllers have enjoyed year-over-year growth with the support of blockbuster introductions and innovative communications strategies, including advertising to consumers. These factors have fueled strong expansion of their respective patient base consistent with the needs of an aging population. Although the span of these categories has increased significantly over the years, patient drop-offs and non-compliance with instructed therapy continue.
GOOD RESEARCH LEADS TO GOOD IDEAS - GOOD IDEAS LEAD TO SMART STRATEGIES
To access the full article you have requested, please create a free membership. With your membership, you will have unlimited access to all of our knowledge resources-white papers, point-of-views, new and archived articles from Ipsos Ideas magazine, and recent Ipsos publications from around the globe- from each of our research specialty practices: advertising, customer loyalty, marketing, public affairs, and forecasting, modeling, and consulting.
In addition, you can choose to receive breaking news, research, and analysis specific to your industry and interests. Member benefits also include invitations to exclusive webinars, local event notification, and more. Sign up is easy, and should only take a moment of your time.